MedTrace Logo

Polyneuropathy and COVID-19

NCT05188690 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2022-01-12

No results posted yet for this study

Summary

Since the onset of the Coronavirus pandemic disease 2019 (COVID-19), the Lombardy region and in particular the territory of the province of Brescia has been heavily affected. Current data show that the total number of confirmed cases in Italy of COVID-19 due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) exceeds 3.9 million cases, with more than 120 thousand deaths. As the COVID-19 epidemic continues to spread globally, more and more evidence is being gathered about the presence of neurological manifestations and symptoms associated with it. With the growing understanding of the disease, many non-pulmonary symptoms have been recognized, including neurological complications such as acute cerebrovascular disease, meningitis, encephalitis, and peripheral nervous system disease. The main objective of this study is to analyze the clinical and functional conditions of COVID-19 patients with an associated diagnosis of polyneuropathy who were admitted for rehabilitation in the rehabilitation centers of Brescia.

Conditions

Interventions

OTHER

Data collection from medical records

Data collection from medical records

Sponsors & Collaborators

  • Fondazione Poliambulanza Istituto Ospedaliero

    collaborator OTHER

  • Fondazione Salvatore Maugeri

    collaborator OTHER

  • Fondazione Don Carlo Gnocchi Onlus

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-01
Primary Completion
2022-01-31
Completion
2022-07-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05188690 on ClinicalTrials.gov